Onconetix, Inc.

ONCO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Oct 23, 2026 CURRENT REPORT
8-K Oct 23, 2026 CURRENT REPORT
425 Oct 23, 2026 FORM 425
ARS Oct 16, 2026 FORM ARS
DEF 14A Oct 7, 2026 DEFINITIVE PROXY STATEMENT
PRE 14A Sep 17, 2026 PRELIMINARY PROXY STATEMENT
DEFA14A Sep 14, 2026 CURRENT REPORT
8-K Sep 14, 2026 CURRENT REPORT
425 Sep 14, 2026 FORM 425
424B3 Sep 8, 2026 PROSPECTUS
EFFECT Sep 3, 2026
425 Sep 3, 2026 FORM 425
S-1/A Aug 31, 2026 AMENDMENT NO. 1 TO FORM S-1
10-Q Aug 13, 2026 QUARTERLY REPORT
S-1 Aug 12, 2026 REGISTRATION STATEMENT
425 Aug 6, 2026 FORM 425
8-K Jul 29, 2026 CURRENT REPORT
SCHEDULE 13G Jul 27, 2026
425 Jul 7, 2026 FORM 425
425 Jun 24, 2026 FORM 425
424B3 Jun 17, 2026 PROSPECTUS
EFFECT Jun 16, 2026
CORRESP Jun 15, 2026
UPLOAD Jun 12, 2026
S-1 Jun 9, 2026 REGISTRATION STATEMENT
← Newer Page 1 of 16 · 393 filings Older →